Overview

Body Weight, Sleep, and Heart Health

Status:
Recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
A multidisciplinary investigation examining the circadian mechanisms regulating cardiovascular (CV) risk in obesity. Specifically, in a valid circadian protocol, the investigators aim to study resting cardiovascular risk markers and the reactivity of circadian rhythms in these risk markers to standardized stressors in obesity. Furthermore, using an ingenious approach, the investigators propose to explore impairment in pre/post synaptic function in the cardiac left ventricle.
Phase:
Early Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Treatments:
CGP 12177